Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019
Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, et al.
Journal of Korean Medical Science (2021) Vol. 36, Iss. 36
Open Access | Times Cited: 17

Showing 17 citing articles:

Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
Young Sang Lyu, Seok Kyu Oh, Jin Hwa Kim, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Utility of Treatment Pattern Analysis Using a Common Data Model: A Scoping Review
Eun-Gee Park, Min Jung Kim, J. Kim, et al.
Healthcare Informatics Research (2025) Vol. 31, Iss. 1, pp. 4-15
Open Access
Incidence and risk factors for periprosthetic joint infection: A common data model analysis
Kee Jeong Bae, Young Ju Chae, Sung Jae Jung, et al.
Joint Diseases and Related Surgery (2022) Vol. 33, Iss. 2, pp. 303-313
Open Access | Times Cited: 13
Efficacy and safety of a fixed‐dose combination of dapagliflozin and linagliptin (AJU‐A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, parallel‐group, placebo‐controlled phase III study
Jun Hwa Hong, Myeong‐Jin Kim, Kyung Wan Min, et al.
Diabetes Obesity and Metabolism (2024)
Open Access | Times Cited: 2
TreatmentPatterns: An R package to facilitate the standardized development and analysis of treatment patterns across disease domains
Aniek F. Markus, Katia Verhamme, Jan A. Kors, et al.
Computer Methods and Programs in Biomedicine (2022) Vol. 225, pp. 107081-107081
Open Access | Times Cited: 10
Prescribing pattern of anti-diabetic drugs and adherence to the American Diabetes Association’s (ADA) 2021 treatment guidelines among patients of type 2 diabetes mellitus: A cross-sectional study
Kalpana Tiwari, Manisha Bisht, Ravi Kant, et al.
Journal of Family Medicine and Primary Care (2022) Vol. 11, Iss. 10, pp. 6159-6164
Open Access | Times Cited: 8
Patterns of initial and first‐intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010–2020: A retrospective population‐based cohort study
Fatema Mahmoud, Tanja Mueller, Alexander B. Mullen, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 7, pp. 2684-2694
Open Access | Times Cited: 1
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country
Nancy Zaghloul, Ahmed Awaisu, Ahmed Mahfouz, et al.
International Journal of Clinical Pharmacy (2022) Vol. 44, Iss. 6, pp. 1342-1350
Open Access | Times Cited: 6
Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study
Hyeong Kyu Park, Kyoung‐Ah Kim, Kyung‐Wan Min, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2743-2755
Closed Access | Times Cited: 3
A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study
Soree Ryang, Sang Soo Kim, Ji Cheol Bae, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 9, pp. 1800-1809
Open Access | Times Cited: 4
Disparity in Guideline‐Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017–2019
Mengyuan Fu, Zhiwen Gong, Yuezhen Zhu, et al.
Pharmacoepidemiology and Drug Safety (2024) Vol. 33, Iss. 8
Closed Access
Real-World Treatment Intensity and Patterns in Patients With Myopic Choroidal Neovascularization: Common Data Model in Ophthalmology
Manh-Hung Bui, Da Yun Lee, Sang Jun Park, et al.
Journal of Korean Medical Science (2023) Vol. 38, Iss. 23
Open Access | Times Cited: 1
Longitudinal treatment patterns in patients recently diagnosed with type 2 diabetes mellitus in Catalonia
Dan Ouchi, Maria Giner‐Soriano, Carles Vilaplana-Carnerero, et al.
Diabetes Research and Clinical Practice (2023) Vol. 202, pp. 110777-110777
Closed Access | Times Cited: 1
Comparative Study of Efficacy and Safety of Lobeglitazone versus Pioglitazone as Add on Therapy to Metformin and Vildagliptin in Patients of Type 2 Diabetes Mellitus
Dr Ram Babu Raman, Asha Kumari, Dr Satya Prakash Singh
International Journal of Pharmaceutical Sciences Review and Research (2023) Vol. 81, Iss. 2
Open Access | Times Cited: 1
Efficacy and Safety of Lobeglitazone versus Pioglitazone as Add on Therapy to Metformin and Vildagliptin in Patients of Type 2 Diabetes Mellitus: A Randomised Controlled Trial
Dr Arun Kumar, Saajid Hameed, Mukesh Kumar, et al.
International Journal of Pharmaceutical Sciences Review and Research (2024) Vol. 84, Iss. 3
Open Access
TreatmentPatterns: An R package to analyze treatment patterns of a study population of interest
Aniek F. Markus, Katia Verhamme, Jan A. Kors, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9)
Da Hea Seo, So Hun Kim
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 6, pp. 956-957
Open Access | Times Cited: 1
Page 1

Scroll to top